📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RPE65 gene therapy slows cone loss in Rpe65-deficient dogs. (2013)

First Author: Mowat FM

Attributed to: Development of an AAV vector for treatment of inherited retinal dystrophy caused by RPE65 deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/gt.2012.63

PubMed Identifier: 22951453

Publication URI: http://europepmc.org/abstract/MED/22951453

Type: Journal Article/Review

Volume: 20

Parent Publication: Gene therapy

Issue: 5

ISSN: 0969-7128